2015-08-06 |
1 |
Complaint |
three API patents, U.S. Patent Nos. 7,674,799, 7,674,800, and 7,683,072 (“the Improved API
patents”), are…claims 3 and 19 of U.S. Patent No. 7,674,799;
claims 30-34 and 76-79 of U.S. Patent No. 7,674,800; claims…infringed U.S. Patent Nos. 7,674,799,
7,674,800, and 7,683,072 (“the Improved API patents”), and that the…right, title and interest in United States Patent No. 7,674,799 entitled
“OXYCODONE HYDROCHLORIDE… infringement of
U.S. Patent No. 8,652,497 (“the ‘497 Abuse-deterrence patent”), which relates to an |
External link to document |
2017-06-01 |
139 |
|
Invalidity And Non-Infringement Of U.S. Patent Nos. 9,073,933, 8,652,497, And 9,155,717, Defendant Collegium… 6 August 2015
1:15-cv-13099-FDS
Patent
Defendant
District Court, D. |
External link to document |
2017-11-21 |
150 |
|
the 8α-removing, low-ABUK patent: U.S.
Patent No. 9,073,933 (“the ’933 Patent”).
1. …oxycodone: U.S. Patent Nos. 8,652,497 (“the ’497 patent”) and 9,155,717 (“the ’717 Patent”).
FAC, Exs. …low-toxicity patent.” (Id.
¶ 3, 12). Purdue Pharmaceuticals L.P. also owns the low-toxicity patent and manufactures… B. Patents at Issue
Purdue Pharma L.P., is the named assignee on two patents related to… The ’497 Patent
The ’497 patent is entitled “Pharmaceutical Formulation Containing Irritant |
External link to document |
2018-02-26 |
165 |
|
counts of infringement of U.S. Patent No. 9,522,919, the only
patent at issue in member case 17-cv-10690… 6 August 2015
1:15-cv-13099-FDS
Patent
Defendant
District Court, D. |
External link to document |